Table 2. Characteristics of individuals receiving post-exposure prophylaxis for rabies, by location of exposure, France, 1995–2016 (n = 106,233).
| Characteristic | Europe (n = 1,990) |
Asia (n = 5,751) |
Americas (n = 1,332) |
Africa (n = 5,677) |
French overseas territories (n = 3,965) |
Mainland France (n = 87,518) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Individuals receiving PEP | n | % | n | % | n | % | n | % | n | % | n | % |
| Median age in years (range) | 33 | 0–96 | 31 | 0–97 | 31 | 1–81 | 32 | 0–95 | 29 | 0–109 | 31 | 0–102 |
| < 15 years old | 328 | 16.5 a | 742 | 12.9 a | 131 | 9.8 a | 1,466 | 25.8 a | 1,132 | 28.5 a | 18,635 | 21.3 |
| Male | 1,076 | 54.1 | 2,813 | 48.9 a | 664 | 49.8 a | 2,922 | 51.5 a | 2,432 | 61.3 a | 48,941 | 55.9 |
| Category III exposure | 1,518 | 76.3 a | 3,654 | 63.5 a | 840 | 63.1 a | 3,439 | 60.6 a | 3,114 | 78.5 a | 73,190 | 83.6 |
| Dog exposure | 1,476 | 74.2 a | 2,793 | 48.6 a | 810 | 60.8 | 2,778 | 48.9 a | 2,015 | 50.8 a | 57,073 | 65.2 |
| Cat exposure | 235 | 11.8 a | 582 | 10.1 a | 93 | 7.0 a | 1,487 | 26.2 a | 325 | 8.2 a | 19,343 | 22.1 |
| Bat exposure | 41 | 2.1 | 39 | 0.7 a | 83 | 6.2 a | 31 | 0.5 a | 838 | 21.1 a | 1,922 | 2.2 |
| NHP exposure | 64 | 3.2 a | 2,007 | 34.9 a | 93 | 7.0 a | 672 | 11.8 a | 159 | 4.0 a | 336 | 0.4 |
| RIG | 289 | 14.5 a | 1,380 | 24.0 a | 313 | 23.5 a | 1,010 | 17.8 a | 873 | 22.0 a | 4,860 | 5.6 |
| Proportion of individuals receiving PEP among all PEP-seeking consultations at antirabies clinics | n/N | % | n/N | % | n/N | % | n/N | % | n/N | % | n/N | % |
| 1,990/2,638 | 75.4 a | 5,751/6,331 | 90.8 a | 1,332/1,520 | 87.6 a | 5,677/6,470 | 87.7 a | 3,965/5,466 | 72.5 a | 87,518/181,871 | 48.1 | |
NHP: non-human primate; PEP: post-exposure prophylaxis; RIG: rabies immunoglobulin.
a Significantly different from individuals exposed in mainland France (p < 0.05).